Non-ownership Filings
| Total Voting Rights and Admission of Shares | May. 01, 2026 |
| FDA ODAC vote on camizestrant in breast cancer | May. 01, 2026 |
| FDA ODAC recommends Truqap in prostate cancer | May. 01, 2026 |
| 1st Quarter Results | Apr. 29, 2026 |
| Breztri approved in the US for asthma | Apr. 28, 2026 |
| Saphnelo self-administration approved in the US | Apr. 27, 2026 |
| Directorate change | Apr. 23, 2026 |
Ownership Update Filings
| Director/PDMR Shareholding | Mar. 06, 2026 |
| Director/PDMR Shareholding | Mar. 06, 2026 |
| Director/PDMR Shareholding | Mar. 06, 2026 |
| Director/PDMR Shareholding | Dec. 22, 2025 |
| Director/PDMR Shareholding | Dec. 19, 2025 |
| Director/PDMR Shareholding | Nov. 14, 2025 |
| Director/PDMR Shareholding | Nov. 10, 2025 |